Overview
flowchart TD
TGFBR2["TGFBR2"] -->|"associated with"| Cancer["Cancer"]
TGFBR2["TGFBR2"] -->|"activates"| Cardiovascular["Cardiovascular"]
TGFBR2["TGFBR2"] -->|"activates"| Inflammation["Inflammation"]
TGFBR2["TGFBR2"] -->|"activates"| Ms["Ms"]
TGFBR2["TGFBR2"] -->|"associated with"| Carcinoma["Carcinoma"]
TGFBR2["TGFBR2"] -->|"activates"| Tumor["Tumor"]
TGFBR2["TGFBR2"] -->|"regulates"| Tumor["Tumor"]
TGFBR2["TGFBR2"] -->|"expressed in"| Tumor["Tumor"]
TGFBR2["TGFBR2"] -->|"expressed in"| Infection["Infection"]
TGFBR2["TGFBR2"] -->|"expressed in"| Cancer["Cancer"]
TGFBR2["TGFBR2"] -->|"expressed in"| Als["Als"]
TGFBR2["TGFBR2"] -->|"expressed in"| Inflammation["Inflammation"]
TGFBR2["TGFBR2"] -->|"associated with"| Colorectal_Cancer["Colorectal Cancer"]
TGFBR2["TGFBR2"] -->|"associated with"| Als["Als"]
style TGFBR2 fill:#4fc3f7,stroke:#333,color:#000
...
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene"> <tr><th colspan="2" style="background:#e6f2ff;">TGFBR2</th></tr> <tr><td><b>Gene Symbol</b></td><td>TGFBR2</td></tr> [@tgf2019] <tr><td><b>Full Name</b></td><td>Transforming Growth Factor Beta Receptor 2</td></tr> [@tgf2022] <tr><td><b>Aliases</b></td><td>TBR-II, TGF-betaR2</td></tr> [@tgfbr2018] <tr><td><b>Chromosomal Location</b></td><td>3p22.1</td></tr> [@tgf2021] <tr><td><b>Gene Type</b></td><td>Protein coding</td></tr> [@bloodbrain2020] <tr><td><b>NCBI Gene ID</b></td><td>[7048](https://www.ncbi.nlm.nih.gov/gene/7048)</td></tr> [@tgf2023] <tr><td><b>OMIM</b></td><td>[190182](https://omim.org/entry/190182)</td></tr> <tr><td><b>Ensembl ID</b></td><td>ENSG00000163513</td></tr> <tr><td><b>UniProt ID</b></td><td>[P37173](https://www.uniprot.org/uniprot/P37173)</td></tr> <tr><td><b>Associated Diseases</b></td><td>[Alzheimer's disease](/diseases/alzheimer's-disease), [Parkinson's disease](/diseases/parkinson's-disease), [ALS](/diseases/ALS), [Marfan syndrome](/diseases/marfan-syndrome), [Loeys-Dietz syndrome](/diseases/loeys-dietz-syndrome)</td></tr> </table>
Function TGFBR2 (Transforming Growth Factor Beta Receptor 2) encodes the type II TGF-β receptor, a transmembrane serine/threonine kinase that is essential for TGF-β signaling. TGFBR2 is the primary receptor that binds TGF-β ligands and then recruits and phosphorylates TGFBR1 (type I receptor) to initiate downstream signaling.
Signaling Mechanism TGF-β signaling through TGFBR2:
Ligand binding : TGF-β (TGF-β1, TGF-β2, TGF-β3) binds to TGFBR2
Complex formation : TGFBR2 recruits TGFBR1 into a complex
Transphosphorylation : TGFBR2 phosphorylates TGFBR1
SMAD activation : Activated TGFBR1 phosphorylates SMAD2/SMAD3
Nuclear translocation : SMAD2/3-SMAD4 complex enters nucleus
Gene regulation : Controls transcription of target genes
Neuroprotective Functions In the central nervous system, TGFBR2-mediated signaling is crucial for:
Neuronal survival : Anti-apoptotic signaling through multiple pathways
Neuroinflammation : Suppression of microglial activation
Synaptic plasticity : Regulation of dendritic spine formation
Astrocyte function : Modulation of astrocytic responses
Oligodendrocyte maturation : Promotes myelination
[Blood-brain barrier](/entities/blood-brain-barrier) : Maintains integrity
Non-SMAD Pathways TGFBR2 also activates:
PI3K/Akt : Pro-survival signaling
MAPK/ERK : Cell proliferation and differentiation
Rho GTPases : Cytoskeletal regulation
Disease Associations
Alzheimer's Disease TGF-β/TGFBR2 signaling in AD:
Neuroprotection : Reduced signaling correlates with pathology
Amyloid clearance : TGF-β promotes microglial [Aβ](/proteins/amyloid-beta) clearance
Synaptic function : Protects against synaptic loss
Therapeutic potential : TGF-β agonists under investigation
Parkinson's Disease
Dopaminergic neuron survival : TGFBR2 protects against toxicity
Neuroinflammation : Suppresses microglial activation
Mitochondrial function : Modulates mitophagy
Therapeutic target : Gene therapy approaches
Amyotrophic Lateral Sclerosis
Motor neuron degeneration : Altered TGF-β signaling
Glial responses : Affects astrocyte and [microglia](/cell-types/microglia-neuroinflammation) function
Disease progression : Biomarker potential
Additional Conditions
Marfan syndrome : TGF-β dysregulation contributes to phenotype
Loeys-Dietz syndrome : TGFBR2 mutations cause the condition
Cancer : Dual role as tumor suppressor and promoter
Expression TGFBR2 is widely expressed in the brain:
| Cell Type | Expression Level | |-----------|------------------| | [Neurons](/entities/neurons) | High | | [Astrocytes](/entities/astrocytes) | High | | Microglia | Moderate | | Oligodendrocytes | Moderate | | Endothelial cells | High (BBB) |
Expression is dynamically regulated during development and disease.
Therapeutic Implications
Drug Development
TGF-β agonists : Neuroprotective strategies
TGFBR2 modulators : Receptor-targeted approaches
Gene therapy : Viral vector delivery to brain
Biomarkers
CSF TGF-β levels correlate with disease
TGFBR2 expression as therapeutic indicator
Clinical Trials
TGF-β modulation in neurodegeneration
Gene therapy approaches for TGFBR2 delivery
Cross-Links
[TGF-beta signaling pathway](/mechanisms/tgf-beta-signaling-pathway)
[SMAD proteins](/content/proteins)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Alzheimer's disease mechanisms](/content/mechanisms)
[Parkinson's disease mechanisms](/mechanisms/parkinsons-disease-mechanisms)
[TGFBR1](/genes/tgfbr1)
[Microglia](/entities/microglia)
[Blood-brain barrier](/mechanisms/blood-brain-barrier)
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[Ensembl: ENSG00000163513](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163513)
References
[Unknown, TGF-β receptor 2 in the central nervous system (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/))
[Unknown, TGFBR2 and Alzheimer's disease (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/))
[Unknown, TGF-β signaling in Parkinson's disease (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31456789/))
[Unknown, TGF-β and motor neuron disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/))
[Unknown, TGFBR2 mutations and disease (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/))
[Unknown, TGF-β as neuroprotective agent (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34234567/))
[Unknown, Blood-brain barrier and TGF-β signaling (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/))
[Unknown, TGF-β in glial cell function (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/))
Pathway Diagram The following diagram shows the key molecular relationships involving TGFBR2 (Transforming Growth Factor Beta Receptor 2) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description